Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

May 16, 2025

Primary Completion Date

November 27, 2028

Study Completion Date

November 27, 2028

Conditions
Atopic Dermatitis
Interventions
DRUG

GHZ339

GHZ339 administered at dose A, B, C and D

DRUG

Placebo

Matching placebo

Trial Locations (39)

11203

RECRUITING

SUNY Downstate Health Science Center, Brooklyn

30342

RECRUITING

Novartis Investigative Site, Atlanta

31217

RECRUITING

Dermatologic Surgery Specialists PC, Macon

RECRUITING

Novartis Investigative Site, Macon

33144

RECRUITING

International Dermatology Research Inc, Miami

RECRUITING

Novartis Investigative Site, Miami

35233

RECRUITING

UAB Dermatology, Birmingham

35244

RECRUITING

Novartis Investigative Site, Birmingham

40241

RECRUITING

Novartis Investigative Site, Louisville

48084

RECRUITING

Novartis Investigative Site, Troy

RECRUITING

Somerset Skin Centre, Troy

RECRUITING

Somerset Skin Centre, Troy

64506

RECRUITING

MediSearch Clinical Trials, Saint Joseph

RECRUITING

Novartis Investigative Site, Saint Joseph

72916

RECRUITING

Johnson Dermatology, Fort Smith

76011

RECRUITING

Arlington Research Center Inc, Arlington

RECRUITING

Novartis Investigative Site, Arlington

77030

RECRUITING

Center for Clinical Studies, Houston

RECRUITING

Novartis Investigative Site, Houston

77433

RECRUITING

Novartis Investigative Site, Cypress

78218

RECRUITING

Novartis Investigative Site, San Antonio

RECRUITING

Texas Derm and Laser Specialists, San Antonio

90056

RECRUITING

Novartis Investigative Site, Los Angeles

RECRUITING

Wallace Medical Group Incorporated, Los Angeles

90404

RECRUITING

Novartis Investigative Site, Santa Monica

92701

RECRUITING

Novartis Investigative Site, Santa Ana

RECRUITING

Southern California Dermatology, Santa Ana

95815

RECRUITING

Integrative Skin Science and Res, Sacramento

200040

RECRUITING

Novartis Investigative Site, Shanghai

02135

RECRUITING

Novartis Investigative Site, Brighton

L8L 3C3

RECRUITING

Novartis Investigative Site, Hamilton

L3P 1A8

RECRUITING

Novartis Investigative Site, Markham

H1Y 3L1

RECRUITING

Novartis Investigative Site, Montreal

271-0092

RECRUITING

Novartis Investigative Site, Matsudo

812-8582

RECRUITING

Novartis Investigative Site, Fukuoka

211-0063

RECRUITING

Novartis Investigative Site, Kawasaki

220-6208

RECRUITING

Novartis Investigative Site, Yokohama

141 8625

RECRUITING

Novartis Investigative Site, Shinagawa Ku

607-8062

RECRUITING

Novartis Investigative Site, Kyoto

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY